FDA
approval
· 2017-10-31
FDA Approved: CALQUENCE — Original Application (AstraZeneca Pharmaceuticals LP)
Summary
FDA approved CALQUENCE (acalabrutinib) from the original application by AstraZeneca Pharmaceuticals LP. This marks the initial approval of acalabrutinib for man…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CALQUENCE (ACALABRUTINIB)